Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors

被引：10

作者：

Choi, Hwanho ^{[1
]}

Park, Ho Jeong ^{[2
]}

Shin, Jong Chul ^{[2
]}

Ko, Hyun Sun ^{[2
]}

Lee, Jung Kyun ^{[3
]}

Lee, Soyoung ^{[4
]}

Park, Hwangseo ^{[1
]}

Hong, Sungwoo ^{[4
]}

机构：

[1] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea

[2] Catholic Univ, Coll Med, Seoul St Marys Hosp, Dept Obstet & Gynecol, Seoul 137040, South Korea

[3] Soomshinun Oriental Med Clin, Yongin 448170, Gyeonggi Do, South Korea

[4] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 06期

基金：

新加坡国家研究基金会;

关键词：

Virtual screening; Docking; p38; MAPK; Inhibitor; Anti-inflammatory agents; GENETIC ALGORITHM; PROTEIN-KINASE; POTENT; SOLVATION; DOCKING; IDENTIFICATION; DESIGN;

D O I：

10.1016/j.bmcl.2012.01.104

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

p38 Mitogen-activated protein kinase (MAPK) has been considered to be a promising target for the development of therapeutics for various immunologic diseases. Herein we report an example for a successful application of the virtual screening with protein-ligand docking to identify the novel inhibitors of p38 alpha MAPK. These inhibitors were screened for having desirable physicochemical properties as a drug candidate and compound 1-3 revealed a moderate inhibitory activity with IC50 values ranging from 0.7 to 20 mu M. Therefore, they deserve a consideration for further development by structure-activity relationship (SAR) studies to optimize the inhibitory activities. Structural features relevant to the stabilization of the newly identified inhibitors in the ATP-binding site of p38 MAPK are addressed in detail. (C) 2012 Elsevier Ltd. All rights reserved.

引用

下载

页码：2195 / 2199

页数：5

共 50 条

[21] A combined 3D QSAR and pharmacophore-based virtual screening for the identification of potent p38 MAP kinase inhibitors: an in silico approach
Gugan Kothandan
Thirumurthy Madhavan
Changdev G. Gadhe
Seung Joo Cho
Medicinal Chemistry Research, 2013, 22 : 1773 - 1787
[22] A combined 3D QSAR and pharmacophore-based virtual screening for the identification of potent p38 MAP kinase inhibitors: an in silico approach
Kothandan, Gugan
Madhavan, Thirumurthy
Gadhe, Changdev G.
Cho, Seung Joo
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (04) : 1773 - 1787
[23] 'Reverse' α-ketoamide-based p38 MAP kinase inhibitors
Montalban, Antonio Garrido
Boman, Erik
Chang, Chau-Dung
Ceide, Susana Conde
Dahl, Russell
Dalesandro, David
Delaet, Nancy G. J.
Erb, Eric
Gibbs, Andrew
Kahl, Jeff
Kessler, Linda
Lundstroem, Jan
Miller, Stephen
Nakanishi, Hiroshi
Roberts, Ed
Saiah, Eddine
Sullivan, Robert
Wang, Zhijun
Larson, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5456 - 5459
[24] Novel inhibitors of p38 MAP kinase.
Shetty, R
Moffett, KK
Nguyen, D
Kelly, MJ
Michelotti, EL
Dorsey, BD
Springman, E
Bukhtiyarova, M
Northrop, K
Chai, XM
Saporito, MS
Ochman, AR
Karpusas, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
[25] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
Rupert, KC
Henry, JR
Dodd, JH
Wadsworth, SA
Cavender, DE
Olini, GC
Fahmy, B
Siekierka, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350
[26] Novel scaffold replacement methodology applied to the discovery of P38 MAP kinase inhibitors
Thorsteinson, Nels
Williams, Christopher
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[27] Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase
Jerome, Kevin D.
Hepperle, Michael E.
Walker, John K.
Xing, Li
Devraj, Rajesh V.
Benson, Alan G.
Baldus, John E.
Selness, Shaun R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (10) : 3146 - 3149
[28] P38 MAP kinase inhibitors for the treatment of arthritis
Barlocco, D
Langston, S
DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809
[29] The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase
Leftheris, K
Ahmed, G
Chan, R
Dyckman, AJ
Hussain, Z
Ho, K
Hynes, J
Letourneau, J
Li, W
Lin, SQ
Metzger, A
Moriarty, KJ
Riviello, C
Shimshock, Y
Wen, J
Wityak, J
Wrobleski, ST
Wu, H
Wu, JJ
Desai, M
Gillooly, KM
Lin, TH
Loo, D
McIntyre, KW
Pitt, S
Shen, DR
Shuster, DJ
Zhang, R
Diller, D
Doweyko, A
Sack, J
Baldwin, J
Barrish, J
Dodd, J
Henderson, I
Kanner, S
Schieven, GL
Webb, M
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6283 - 6291
[30] Novel scaffold replacement methodology applied to the discovery of P38 MAP kinase inhibitors
Leonard, Joe
Thorsteinson, Nels
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240

← 1 2 3 4 5 →